NCLEX Uworld Practice Test

Hydroxychloroquine is favored for treating the skin and joint manifestations of lupus because it modulates the immune response in a way that reduces both skin rashes and joint inflammation without the broad, rapid suppression seen with steroids. It helps control mucocutaneous lupus (rash, photosensitivity) and lupus arthropathy over time and also lowers the frequency of disease flares, making it a cornerstone of long-term management. Mechanistically, it dampens immune signaling that drives inflammation, which translates into better skin and joint symptoms while generally having a more favorable safety profile than sustained high-dose corticosteroids or other immunosuppressants. Prednisone may quickly quell inflammation during a flare but isn’t the long-term solution for skin and arthritis. Methotrexate and azathioprine can be used for arthritis or more severe organ involvement, but they’re not the first-line choices specifically for skin and joint symptoms in lupus. Hydroxychloroquine stands out for these manifestations and is commonly continued as maintenance therapy. If used, it requires regular eye exams due to the risk of retinal toxicity.